{"name":"Biotheus Inc.","slug":"biotheus-inc","ticker":"","exchange":"","domain":"biotheus.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"PM8002","genericName":"PM8002","slug":"pm8002","indication":"Type 2 diabetes","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"PM1021, PM8001","genericName":"PM1021, PM8001","slug":"pm1021-pm8001","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"PM8002","genericName":"PM8002","slug":"pm8002","phase":"phase_3","mechanism":"PM8002 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"PM1021, PM8001","genericName":"PM1021, PM8001","slug":"pm1021-pm8001","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxPVVRucTlhdkxaRm9TSGxENkRvZE1aREw2NDd1a0ZNajNfclRkZVdaWjhMUFRoNkdpZnJoVUFhRTI3R0xpS3R0NV82Qzh4TzUxaVBrYmwwVWNTUWRaZkswYmZFZ0ppTmNzX3RWZVRtRVRFRmlvVmV5YUNwa3d1UFZTM0d1dGU4R0p2aTgtMS0tdDhkZ3E3dWhOZ3lfNXlNQnVvSW10VllNZFdQTUE4dlpJLTh4STlLb25CNVQxUE5EamswZmlh?oc=5","date":"2025-10-24","type":"deal","source":"BioCentury","summary":"LaNova’s Crystal Qin wins woman leadership prize as dealmakers shape BayHelix awards - BioCentury","headline":"LaNova’s Crystal Qin wins woman leadership prize as dealmakers shape BayHelix awards","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE8wWk1YNUM2V0dHMS16MWx4MVhFcVljU0hKRDBfNWFZYjAyV1ZrWVN6elU3bWw3bkxOTWpPQ3I5VXRIV2tOWUFmdUZEMW1oMkNBTzU4Ulh2QjhqZXRGWDNZSFFBU05QMWhjRHlubXFTRjE1VWVaeFNPTUtaUUM?oc=5","date":"2025-06-19","type":"pipeline","source":"ThinkChina","summary":"Chinese biotech is having a ‘DeepSeek moment’ - ThinkChina","headline":"Chinese biotech is having a ‘DeepSeek moment’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQb3RzeUFXZkVBNmVxdVRRdjRIRFg2T2lfd1haaHhvMFZrR1ZUaGY2RTRLM3B5cXJrbnlwWVNlSXIxQUNCY2JST0tCZXZyY2FDSzlhOE1CTWJmZ2RpZU80eGdndVNMNGtVU3loRjlkWGxIRWxERVhyTGtQM3VmX0t1dVFTT3NoNW8?oc=5","date":"2024-11-13","type":"deal","source":"pharmaphorum","summary":"BioNTech buys Biotheus and its Keytruda rival for $950m - pharmaphorum","headline":"BioNTech buys Biotheus and its Keytruda rival for $950m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQUExxSi1UeFNST1R2Z0RHRmIxSFNNdE9vdUE3aWp1WVI3LXVObVlqQjBBZjY5YWNDdWpYZ21VRFZZRXZMNTYyUkt6TnBVTWEzN3R6dkthZmk5R012SDNuZ1kyNy0xbTJCOFFDUG5NS3FkM011NFRoV1hIdmdYSnpkVmpndmtRNmhaQ1dvV0hVeWpzODFHbU84?oc=5","date":"2024-11-13","type":"deal","source":"BioPharma Dive","summary":"BioNTech to buy Biotheus, gaining control of cancer bispecific - BioPharma Dive","headline":"BioNTech to buy Biotheus, gaining control of cancer bispecific","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNdUM1UWVnZVNQbUF0T0ZlQ2JuOTAxT2p4RjEyc3pHVHBhclM2S1lpdUJTM1hlWUV2ZWtHbmxrc09wMDRBNGc4M25XeURPcXRLVEtpc09Nc1B3NmtmRmhldmNSSFM2V3E0WHRlQmdZNDVSUUNuQlZSd1JTQy1tcUh5YjZBaUY?oc=5","date":"2024-11-13","type":"deal","source":"Financial Times","summary":"BioNTech strikes $950mn deal for Chinese drugmaker Biotheus - Financial Times","headline":"BioNTech strikes $950mn deal for Chinese drugmaker Biotheus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPN3RBVERiVm8tVHpMZFI3LW9iQVdkV3htYzUyVFR6VjJJV3ZPc204NzRDRUVwUWRCS2FGcFlUSUlYNHhZR1cyYzVxSS1mMkRuLTBqeXMwUGRKZE5EbXZ2VFRFc1EwVFF3S2F6OGx3a0NxaVlGOEhZbnJUdXhKcXBEel8wREZRWURUXzcwcmluRno0bTRLTVZuU3NXTEY1ck4wZjBOTTZXT1U?oc=5","date":"2024-11-13","type":"deal","source":"Reuters","summary":"BioNTech buys China's Biotheus to support oncology strategy - Reuters","headline":"BioNTech buys China's Biotheus to support oncology strategy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOdHg4NG5EeEhuVjVBam9LNkZpUjVQYjJYS3NncG94THZVSjRxTWFoamxVbkNGTXByeVpvTGgzS3VNMzN3WVZxZEphVTRtX3NIejlUZHM4WE94WlZ5MC11OUUyRmxhbVNDMm1TYk9vRzU1bVlES0lIWEJVLWVFdy1OVWZqWEJONWZnM0o4Njdfdy0taDVLVXFLU0Q1VXFnUmY2?oc=5","date":"2024-10-03","type":"deal","source":"Pharmaceutical Technology","summary":"ImmunoPrecise and Biotheus partner on bispecific antibodies to treat cancer - Pharmaceutical Technology","headline":"ImmunoPrecise and Biotheus partner on bispecific antibodies to treat cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOcVZRRENYWF9Ld09GXzVFS1g5a0VfUHREMzhTSXp0SGVPZ3BIN2JiVjdpclFpZjdGQWh4eHZrekFzWW9FcnpwM3I0Q2VnTzUzTUNBc0hjenN1dVdOeTFtbzl3dEVYVnRqcHpTT2FyM3F3Zkg3bFNPNGVoS0tCUF9lMWY2RzR1eUhGcklRTjBGcjhBVHpfZnFhZ2NmYzRYVDhMM1U4MA?oc=5","date":"2024-03-18","type":"deal","source":"BioWorld News","summary":"Biotheus, Hansoh ink potential ¥5B deal for new bispecific ADCs - BioWorld News","headline":"Biotheus, Hansoh ink potential ¥5B deal for new bispecific ADCs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPQWx5NDZjbjFXb05xYkxHc2sxOFp0c3NCZy1yb21yQTJuTUdYelJGV01CMHhYRjE5NUQwaDNLM3g4SDNjTnpCMlZZVldwMTVUM0Q1XzVwbmFhbmhjRnQzdW9LUFlUYzBTR3pGaTZVanlKWkZ3LTBqX3k3c0N4clI1R3k2UnBJZ0xtbThMYmllZWhKdjczYzJGeHdzMTY4NWhVQ21xSjlLZ3p5SlBuXzlPTloxcV85bmhndkJXRg?oc=5","date":"2024-03-15","type":"deal","source":"Contract Pharma","summary":"Biotheus and Hansoh Pharma Expand Collaboration for Novel Cancer Treatment - Contract Pharma","headline":"Biotheus and Hansoh Pharma Expand Collaboration for Novel Cancer Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQZXFTM1ZoeXQwZ2VoOFdpOFIwbGR4OHBtaWlMZ01xYkJNeFN1Z1lsUDlDSVhORzRlVmJXMV9zMlVITVVXamZPRDJKNUJTUVVNa0dQdW1NMmIyb085ME5pM1FyWDI0RUI2RjBmN2pLa3JaVWlWQU5KRTV6dm5zYk9tSldxLTBueWRUTHczNWpOUU43c0Zab0Z1eUZZbnhlY1R3MzR4dE9HU3BWMXMyVzFLaWpHTHgzUFJlRDlTZTRTcw?oc=5","date":"2024-03-15","type":"deal","source":"Fierce Biotech","summary":"Hansoh, fresh from Big Pharma deal table, signs $690M ADC pact with Biotheus - Fierce Biotech","headline":"Hansoh, fresh from Big Pharma deal table, signs $690M ADC pact with Biotheus","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxNMExadERKREttazVrWTVIVkdrVkxGLWpyRFZRMEE2dnpvYzBlYnMycFkwSUQyeWE2d2hLemxySnBDVkdMMEJGREhvX1Z5WURmNXZyV2c4Q0l1dXE5cjRGdWdQandnRV9zM0lQRWh2YndRNHVPQnRaLVAwbmxueHBNcUxn?oc=5","date":"2024-03-15","type":"deal","source":"BioSpace","summary":"Biotheus, Hansoh Expand Partnership in $694M ADC Deal - BioSpace","headline":"Biotheus, Hansoh Expand Partnership in $694M ADC Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQbTIyYUhyd25xX0hQWTl4SUV5QlA2dzBQQjNwUGlGVFlKOTY3VlBhc0I3Z21UQjM4UEx5dk5uTEMtN3VvR01ZcGFFU1ZHeGhUOHczNUFCbzZINzJNQ25xTlREOW11bEtYNHVEWUpRc1RPMzRLVW5NWlZCVlBHQ0hlVFRBWkkxbEx3ckRwZHRuU3RWNkRG?oc=5","date":"2022-11-15","type":"pipeline","source":"Labiotech.eu","summary":"Biotheus enters agreement with Hansoh Pharma for bispecific antibody - Labiotech.eu","headline":"Biotheus enters agreement with Hansoh Pharma for bispecific antibody","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":1,"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}